LONVOGA

Serial Number 88840326
606

Registration Progress

Application Filed
Mar 19, 2020
Under Examination
Dec 22, 2020
Approved for Publication
Oct 27, 2020
Published for Opposition
Oct 27, 2020
Registered

Trademark Image

LONVOGA

Basic Information

Serial Number
88840326
Filing Date
March 19, 2020
Published for Opposition
October 27, 2020
Abandonment Date
January 23, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 23, 2023
Classes
005

Rights Holder

Actelion Pharmaceuticals Ltd.

16
Address
Gewerbestrasse 16
Allschwil 4123
CH

Ownership History

Actelion Pharmaceuticals Ltd.

Original Applicant
16
Allschwil CH

Actelion Pharmaceuticals Ltd.

Owner at Publication
16
Allschwil CH

Legal Representation

Attorney
CHERYL FOYTLIN

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description Documents
Jan 23, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 23, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 17, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 14, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 14, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 23, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 21, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 21, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 22, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 27, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 27, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 7, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 23, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 21, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 21, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 21, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 19, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 23, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005